This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tohoku University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Masakuni Horiguchi: Innovator in Therapeutic Agents for Amyotrophic Disorders
Introduction
Masakuni Horiguchi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the development of therapeutic agents for amyotrophic disorders. His work aims to address critical health issues affecting individuals with neurogenic and myogenic amyotrophic diseases.
Latest Patents
Horiguchi holds a patent for a therapeutic agent designed to treat amyotrophic diseases. This invention focuses on providing a novel method for treating conditions such as amyotrophic lateral sclerosis (ALS) and sarcopenia. The therapeutic agent comprises one or more compounds represented by specific chemical formulas, along with their pharmaceutically acceptable salts.
Career Highlights
Masakuni Horiguchi is affiliated with Tohoku University, where he has been involved in groundbreaking research. His dedication to advancing medical treatments has positioned him as a key figure in the field of therapeutic innovations.
Collaborations
Horiguchi has collaborated with esteemed colleagues, including Takaaki Abe and Yuji Matsumoto. These partnerships have enhanced the research and development of effective treatments for amyotrophic disorders.
Conclusion
Masakuni Horiguchi's contributions to the field of therapeutic agents for amyotrophic disorders highlight his commitment to improving patient outcomes. His innovative work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile